Navigation Links
uBiome Awarded Eighth Patent for the Characterization of Skin Related Conditions
Date:4/1/2019

uBiome announces the issue of patent number 10,169,541 entitled “Method and System for Characterizing Skin Related Conditions” by the US Patent and Trademark Office on January 1, 2019 with a priority date of October 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and Dr. Catalina Valdivia, and expands upon its current intellectual property portfolio.

The patented technology involves characterizing a skin-related condition such as eczema, dry skin, photosensitivity, dandruff, and acne, among others. Further, the patent involves developing a therapy to prevent or ameliorate skin-related conditions by analyzing biological samples from uBiome’s patented kits.

This issuance will lead to further development in characterizing and designing therapies for skin-related conditions which may include probiotic, prebiotic, antibiotic, antifungal, phage-based, small molecule-based, cognitive/behavioral, physical, clinical, medication-based, and diet-related therapies. Together, these potential impacts could improve the treatment and management of skin-related conditions in an individualized and population-wide manner.

“With this patent, we hope to advance the science of skin-related conditions, which are on the rise and already affect millions of people worldwide,” Jessica Richman, PhD, co-founder and CEO of uBiome, said. “We are thrilled to continue expanding our intellectual property and growing our patent portfolio, currently the largest in the microbiome space.”

For more information about our science and patents, visit http://www.ubiome.com/science/#patents.

_____
About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

Read the full story at https://www.prweb.com/releases/ubiome_awarded_eighth_patent_for_the_characterization_of_skin_related_conditions/prweb16208606.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. uBiome Appoints Dr. Steven Medwell, MD, Distinguished Colorectal Surgeon, to its Medical Advisory Board
2. uBiome Appoints Kathie Swift, MS, RDN, FAND, Co-founder of the Integrative and Functional Nutrition Academy, to its Scientific Advisory Board
3. uBiome Appoints Dr. Jonathan Braun, MD, PhD, Prominent UCLA Physician-Researcher, to its Scientific Advisory Board
4. uBiome Appoints Dr. Donnica Moore, MD, Women's Health Expert and Advocate, to its Medical Advisory Board
5. uBiome Appoints Leading Biochemist Dr. Joseph DeRisi to Board of Directors
6. uBiome Appoints Dr. Catherine Lozupone, PhD, Respected Microbiologist, to its Scientific Advisory Board
7. uBiome Appoints Dr. Jill Carnahan, MD, Functional Medicine Expert, to its Medical Advisory Board
8. uBiome Appoints Dr. Emeran Mayer, MD, World-Renowned Gastroenterologist and Neuroscientist, to its Medical Advisory Board
9. uBiome Appoints Dr. Brandon Wuerth, MD, Founder of IBDwatch, to its Medical Advisory Board
10. uBiome Appoints Dr. Amir Zarrinpar, MD, PhD, Assistant Professor in the Division of Gastroenterology at UC San Diego, to its Medical Advisory Board
11. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2019)... ... April 02, 2019 , ... Researchers from Ambry Genetics ... RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant ... poster, is one of 13 presentations at the 2019 American College of Medical ...
(Date:4/1/2019)... ... April 01, 2019 , ... ... Characterizing Skin Related Conditions” by the US Patent and Trademark Office on January ... an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:3/29/2019)... ... ... In the development of biosimilars, the broad definition of the similarity concept in ... several manufacturers have been successful and numerous follow-on biologics are approved in the US ... analytical similarity is achieved in biosimilars based on recently approved products in the US. ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud ... it has begun offering NVIDIA® DGX-1™ deep learning systems as part of its ... provide the highest performance for artificial intelligence and deep learning research and development. ...
(Date:3/14/2019)... OKLAHOMA CITY (PRWEB) , ... March 14, 2019 ... ... AAALAC International for their facility in Oklahoma City, OK. EyeCRO joins the Department ... University of Oklahoma Health Sciences Center as the fifth institution in Oklahoma to ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON ... its Canadian partner, the Eye Machine Canada Inc., had been given approval to ... for treating Age-Related Macular Degeneration (AMD). , The previous month, the medical devices ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
Breaking Biology Technology: